Skip to content
← Full study record

NCT00066573 · BASELINE

Baseline characteristics

Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer · Source last updated 2023-08-25

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      3789
    2. group Id
      BG001
      value
      3787
    3. group Id
      BG002
      value
      7576
    units
    Participants
groups
  1. description
    Patients receive oral exemestane (25 mg) once daily for 5 years. exemestane: Given orally
    id
    BG000
    title
    Exemestane
  2. description
    Patients receive oral anastrozole (1 mg) once daily for 5 years. anastrozole: Given orally
    id
    BG001
    title
    Anastrozole
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          35.9
          upper Limit
          93.6
          value
          63.9
        2. group Id
          BG001
          lower Limit
          32.3
          upper Limit
          95.1
          value
          64.3
        3. group Id
          BG002
          lower Limit
          32.3
          upper Limit
          95.1
          value
          64.1
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          3789
        2. group Id
          BG001
          value
          3787
        3. group Id
          BG002
          value
          7576
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      3789
    2. group Id
      BG001
      value
      3787
    3. group Id
      BG002
      value
      7576
    units
    Participants
groups
  1. description
    Patients receive oral exemestane (25 mg) once daily for 5 years. exemestane: Given orally
    id
    BG000
    title
    Exemestane
  2. description
    Patients receive oral anastrozole (1 mg) once daily for 5 years. anastrozole: Given orally
    id
    BG001
    title
    Anastrozole
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          35.9
          upper Limit
          93.6
          value
          63.9
        2. group Id
          BG001
          lower Limit
          32.3
          upper Limit
          95.1
          value
          64.3
        3. group Id
          BG002
          lower Limit
          32.3
          upper Limit
          95.1
          value
          64.1
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          3789
        2. group Id
          BG001
          value
          3787
        3. group Id
          BG002
          value
          7576
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice